Frankfurt (dpa) – Biotech firms in Germany raised notably less money last year than in 2024, according to a report released by the consultancy firm EY and the BIO Deutschland industry association. Against the backdrop of a weak economy, biotech firms received around €1.8 billion (about $2 billion) from investors and through share issues on the stock market […]